Extract the potential

Santhera Pharmaceutical

Associate Sponsor

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the discovery, development and marketing of innovative pharmaceutical products for the treatment of orphan neuromuscular diseases. Santhera currently has three compounds in seven clinical-stage development programs.

Santhera's vision is to become a leading specialty pharmaceutical company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indications with no current therapy.

Associate Sponsor
Lysogene at World Orphan Drug Congress 2011
Associate Sponsor
Shire Human Genetic Therapies at World Orphan Drug Congress 2011
Associate Sponsor
AVI BioPharma at World Orphan Drug Congress 2011
Associate Sponsor
Oxon Epidemiology at World Orphan Drug Congress 2011
Associate Sponsor
Centric Health Resources at World Orphan Drug Congress 2011
Associate Sponsor
Clinigen Healthcare Limited at World Orphan Drug Congress 2011
Associate Sponsor
Charles River Discovery & Imaging Services at World Orphan Drug Congress 2011
Associate Sponsor
Santhera Pharmaceutical at World Orphan Drug Congress 2011
Associate Sponsor
QCTR Ltd at World Orphan Drug Congress 2011
Associate Sponsor
PSR Group B.V at World Orphan Drug Congress 2011
sponsors list

 

The World Orphan Drug Congress is a multi-faceted event

  • A three day conference
  • case studies by industry professionals
  • Speed networking
  • Interactive panel discussions
  • Roundtable brainstorms
  • Live debates

Register now ›
Download prospectus ›

You may also like to attend:

  • European Antibody Congress
  • World Influenza Congress Europe
  • World Vaccine Congress Lyon

See more ›